Bionet Therapeutics Corp. (7808)
Market Closed
11 Aug, 05:30
TWSE TWSE Primary NT$
30. 10
-0.2
-0.6601%
NT$
2.76B Market Cap
- P/E Ratio
- Div Yield
2,570 Volume
- Eps
NT$ 30.3
Previous Close Want to track 7808 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bionet Therapeutics Corp. (7808) Statistics
Valuation metrics
Market Cap 2.76B
Enterprise value 1.71B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) 17.85
Price/Book (mrq) 2.27
Enterprise Value/Revenue 11.06
Enterprise Value/EBITDA -16.21
Overview
Shares outstanding 70M
Float 34.9M
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 55.17K
Average volume (90 days) 29.73K
Price summary
52-Week low 28.55
52-Week high 66.3
Beta -
50-Day moving average 44.29
200-Day moving average 52.66
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.63%
Operating margin -0.68%
Operational effectiveness
Return on assets -0.06%
Return on equity -0.08%
Income Statement
Revenue (ttm) 154.48M
Revenue per share (ttm) 2.21
Quarterly revenue growth (yoy) 1.13%
Gross profit (ttm) 61.65M
EBITDA -105.43M
Net income to common (ttm) -97.43M
Diluted EPS (ttm) -1.39
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 1.06B
Total cash per share (mrq) 15.14
Total debt (mrq) 10.9M
Total Debt/Equity (mrq) 0.9
Current ratio (mrq) 19.7%
Book value per share (mrq) 17.36
Cash Flow
Cash flow statement -57.48M
Levered free cash flow (LFCF) -140.06M
